A Pilot Study Exploring the Association of Entacapone, Gut Microbiota, and the Subsequent Side Effects in Patients With Parkinson's Disease/Experiment 1/Signature 1
From BugSigDB
Needs review
Source: Figure 3, text
Description: ASVs that significantly differed in abundance before and after the treatment of entacapone. 108 ASVs were identified as significantly different after the treatment of entacapone. 3 ASVs that were not assigned taxonomy to the genus level had a decrease in abundance. They were removed for plotting purposes. Genus and phylum level classification of the significant ASVs are provided in the plot. Genus in bold are unique to our study when compared with Weis et al. (2019).
Abundance in Group 1: increased abundance in Parkinson's disease (PD) patients treated with both levodopa and Entacapone (PD_LE)
| NCBI | Quality Control | Links |
|---|---|---|
| Bifidobacterium | ||
| Christensenellaceae R-7 groupChristensenellaceae R-7 group | ||
| Eubacterium |
Revision editor(s): Fiddyhamma
